Annals of Clinical and Translational Neurology

Annals of Clinical and Translational Neurology is a fully open-access, online-only journal published by Wiley for the American Neurological Association, launched in 2014, with a 2025 Journal Impact Factor of 3.9《临床与转化神经病学年鉴》（Annals of Clinical and Translational Neurology）是（Wiley）为（American Neurological Association）出版的完全开放获取、纯在线期刊，2014 年创办，2025 年影响因子为 3.9。

Scope

• The journal publishes original research and scholarly reviews on disorders of the nervous system该刊发表关于神经系统疾病的原创研究与学术综述。
• It focuses on the mechanisms and treatments of neurological disease其聚焦神经疾病的机制与治疗。
• Topics include clinical trials, biomarkers and translational neuroscience主题包括临床试验、生物标志物与转化神经科学。
• High-impact topics in neurologic education are also within scope神经病学教育领域的高影响力议题亦属收稿范围。
• The journal offers rapid dissemination of peer-reviewed research该刊快速传播经同行评审的研究。
• It serves neurologists, neuroscientists and clinical researchers其服务神经科医师、神经科学家与临床研究者。

History

• Annals of Clinical and Translational Neurology was launched in 2014《临床与转化神经病学年鉴》于 2014 年创办。
• It is published by Wiley on behalf of the American Neurological Association该刊由（Wiley）代表（American Neurological Association）出版。
• It was created as an online-only, fully open-access journal其创刊即为纯在线、完全开放获取期刊。
• All articles are published under a Creative Commons license所有文章均以知识共享许可协议发表。
• It is indexed in SCIE, Scopus and PubMed该刊被（SCIE）、（Scopus）与（PubMed）收录。
• Its 2025 Journal Impact Factor is 3.9, matching the 3.9 of 2024其 2025 年影响因子为 3.9，与 2024 年的 3.9 持平。

Editors

• The Editor-in-Chief is Ahmet Hoke现任主编为（Ahmet Hoke）。
• He is a neurologist and neuroscientist at Johns Hopkins他是约翰斯·霍普金斯大学的神经科医师与神经科学家。
• He succeeded John A. Kessler as editor-in-chief他接替（John A. Kessler）出任主编。
• An international editorial board supports the review process国际编委会支持评审工作。
• Manuscripts are peer-reviewed before publication稿件在出版前均经同行评审。